PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver
- PMID: 32509828
- PMCID: PMC7262620
- DOI: 10.21037/hbsn.2019.10.35
PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2019.10.35). NAT, MD reports grants from Gilead Sciences, personal fees from Intercept, personal fees from EXIFI Management Consultants, LLC, outside the submitted work. The other author has no other conflicts of interest to declare.
Figures
Comment on
-
New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease.Hepatobiliary Surg Nutr. 2018 Oct;7(5):372-381. doi: 10.21037/hbsn.2018.08.05. Hepatobiliary Surg Nutr. 2018. PMID: 30498712 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources